Skip to main content
Dryad

Targeting the glycan of receptor binding domain with jacalin as a novel approach to developing treatment against COVID-19

Data files

Aug 24, 2020 version files 2.75 MB

Abstract

In silico analysis revealed that a lectin, jacalin from jackfurit seeds recognize glycosylated region of receptor binding domain (RBD) of COVID-19. Jacalin binding induce conformational changes in RBD and significantly affect its interaction with human angiotensin-converting enzyme 2. The result may open up exploration of lectins based strategies against COVID-19.In silico analysis revealed that a lectin, jacalin from jackfurit seeds recognize glycosylated region of receptor binding domain (RBD) of COVID-19. Jacalin binding induce conformational changes in RBD and significantly affect its interaction with human angiotensin-converting enzyme 2. The result may open up exploration of lectins based strategies against COVID-19.